Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Can Diversified Healthcare Conglomerates Maintain Growth Despite Patent Expiration Challenges?
1+ hour, 33+ min ago (22+ words) Kalkine Media How Are Metals and Mining Companies Adapting Production Strategies to?...
What Impact Are Artificial Intelligence Systems Having on Healthcare Company?
1+ hour, 33+ min ago (12+ words) Kalkine Media...
Children's Medical Center Dallas Becomes Second U.S. Hospital to Adopt Imricor Medical Systems' NorthStar iMR Technology
1+ hour, 36+ min ago (58+ words) Kalkine Media Why Did Westpac (ASX:WBC) Drag Australian Shares Lower? Why Did Newmont (ASX:NEM) Shine as Banks Dragged the ASX? Why Did CAR Group (ASX:CAR) Defy a Weaker Australian Market? Why Are 4DMedical (ASX:4DX) and DroneShield Under Pressure?...
Which Healthcare Subsectors Are Demonstrating Strongest Momentum During the?
1+ hour, 33+ min ago (11+ words) Kalkine Media...
Encompass Health Submits Q2 2026 Form 10-Q Report to SEC
2+ day, 17+ hour ago (49+ words) Kalkine Media Please verify your e-mail to complete the registration Hey! We have sent you a verification e-mail. Please follow the instructions on the e-mail to complete your registration. If you can't find it, Please check your spam folder...
How Are Healthcare Equipment Manufacturers Addressing Accelerating Demand for Medical Devices?
3+ day, 3+ hour ago (13+ words) Kalkine Media...
ResMed moves into focus as sleep-care demand
5+ day, 22+ hour ago (33+ words) Kalkine Media Cochlear sets the tone after implant uptake ResMed moves into focus as sleep-care demand Vanguard Australian Shares draws attention on index appetite...
Amplia Therapeutics Publishes Preclinical Pancreatic Cancer Study on Narmafotinib via bioRxiv
1+ week, 3+ day ago (13+ words) Kalkine Media...
Neurotech International Receives FDA IND Approval for NTI164, Progresses Phase 3 Autism Study
1+ week, 3+ day ago (15+ words) Kalkine Media...